semaglutide y tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Semaglutide vs Tirzepatide vs Liraglutide

doi: 10.1016/j.intimp.2019.105969

Key Points Native human GLP-1 normalizes hyperglycaemia in patients with type 2 diabetes mellitus, but the short in vivo half-life of this hormone limits its therapeutic application A number of synthetic GLP-1 receptor agonists, with half-lives between 23 h and several days, have been developed for the long-term treatment of type 2 diabetes mellitus Short-acting GLP-1 receptor agonists (such as exenatide and lixisenatide) predominantly lower postprandial glucose levels and insulin concentrations via retardation of gastric emptying Long-acting GLP-1 receptor agonists (such as albiglutide, dulaglutide, exenatide long-acting release and liraglutide) predominantly lower blood glucose levels through stimulation of insulin secretion and reduction of glucagon levels Adverse effects of GLP-1 receptor agonists include nausea, vomiting and diarrhoea, injection-site reactions, antibody formation and increased heart rate This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 119.00 per year only 9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Weight loss can improve fertility, and some women have reported unexpected pregnancies during semaglutide treatment

Heres what you need to know about whether your Medicaid coverage will pay for Ozempic

Yes, Retatrutide shows clinically significant results in as little as 24 weeks, but losing weight too quickly can lead to other issues

Trial data have shown weight reductions of up to approximately 22% in clinical studies